(2) Where an offence under these Regulations is committed by a body corporate or firm
or other association of individuals:-
20.
(a)
every director, manager, secretary or other similar officer of the body corporate;
or
(b)
every partner or officer of the firm; or
(c)
every trustee of the body concerned; or
(d)
every person concerned in the management of the affairs of the association; or
(e)
every person who was purporting to act in a capacity referred to in this regulation,
are severally guilty of that offence and liable to be proceeded against and
punished for that offence in the same manner as if they had themselves committed
the offence unless they prove that the act or omission constituting the offence
took place without their knowledge, consent or connivance.
Forfeiture.
In addition to the penalty specified in regulation 19 of these Regulations, a person
convicted of an offence under these Regulations shall forfeit to the Agency the Drug Product and
whatsoever is used in connection with the commission of the offence.
21.
Interpretation
In these Regulations, unless the context otherwise requires “active ingredient” means any component that is intended to furnish pharmacological
activity or other direct effect in the diagnosis, cure, mitigation, treatment or prevention of
disease or to affect the structure or any function of the body of humans and the term
includes those components that may undergo chemical change in the manufacture of the
drug product and be present in the drug product in a modified form intended to furnish
the specified activity or effect;
“Agency” means The National Agency for Food and Drug Administration and Control;
“batch” means a defined quantity of material manufactured in one process, a series of
processes or in a given part of a continuous process so that it may be expected to be
homogeneous;
“common name” means with reference to a drug, the name in English Language by
which the drug is commonly known;
“Council” means the Governing council of the Agency;
9